SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Shawn Tsai-Shyang

(Last)

(First)

(Middle)

1251 MCKAY DRIVE

(Street)

SAN JOSE

95131

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/24/2017

3. Issuer Name and Ticker or Trading Symbol
SYNAPTICS Inc [ SYNA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	15,266⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	⁽²⁾	01/28/2020	Common Stock	5,780⁽³⁾	$35.76	D
Employee Stock Option (Right to Buy)	⁽⁴⁾	10/28/2020	Common Stock	287⁽⁵⁾	$46.5	D
Employee Stock Option (Right to Buy)	⁽⁶⁾	01/27/2021	Common Stock	335⁽⁷⁾	$60.22	D
Employee Stock Option (Right to Buy)	⁽⁸⁾	04/28/2021	Common Stock	382⁽⁹⁾	$61.4	D
Employee Stock Option (Right to Buy)	⁽¹⁰⁾	08/01/2021	Common Stock	431⁽¹¹⁾	$78.11	D
Employee Stock Option (Right to Buy)	⁽¹²⁾	10/24/2021	Common Stock	269⁽¹³⁾	$62.105	D
Employee Stock Option (Right to Buy)	⁽¹⁴⁾	01/30/2022	Common Stock	296⁽¹⁵⁾	$76.81	D
Employee Stock Option (Right to Buy)	⁽¹⁶⁾	04/24/2022	Common Stock	322	$85.69	D
Employee Stock Option (Right to Buy)	⁽¹⁷⁾	07/31/2022	Common Stock	322	$79.38	D
Employee Stock Option (Right to Buy)	⁽¹⁸⁾	10/23/2022	Common Stock	704	$89.29	D
Employee Stock Option (Right to Buy)	⁽¹⁹⁾	01/29/2023	Common Stock	705	$73.31	D
Employee Stock Option (Right to Buy)	⁽²⁰⁾	04/29/2023	Common Stock	705	$71.55	D
Employee Stock Option (Right to Buy)	⁽²¹⁾	07/29/2023	Common Stock	705	$51.95	D

Explanation of Responses:

1. Includes (i) 1,396 shares that were acquired pursuant to the Issuer's employee stock purchase plan; (ii) 4,868 shares that were acquired upon delivery of vested deferred stock units; and (iii) 9,002 shares underlying deferred stock units that are not yet vested and deliverable.

2. 1/3rd of the 23,500 shares subject to the option granted on 1/28/13 vested and became exercisable on 11/12/13 and 1/36th of the shares subject to the option vested and became exercisable on the 12th day of each month thereafter until fully vested on 11/12/15.

3. Does not include 17,720 shares underlying the option that were previously exercised and sold.

4. 1/12th of the 573 shares subject to the option granted on 10/28/13 vested and became exercisable each quarter commencing on 1/28/14 until fully vested on 10/28/16.

5. Does not include 286 shares underlying the option that were previously exercised and sold.

6. 1/12th of the 573 shares subject to the option granted on 1/27/14 vested and became exercisable each quarter commencing on 4/27/14 until fully vested on 1/27/17.

7. Does not include 238 shares underlying the option that were previously exercised and sold.

8. 1/12th of the 573 shares subject to the option granted on 4/28/14 vested and became exercisable each quarter commencing on 7/28/14 until fully vested on 4/28/17.

9. Does not include 191 shares underlying the option that were previously exercised and sold.

10. 1/12th of the 574 shares subject to the option granted on 8/01/14 vested and became exercisable each quarter commencing on 11/01/14 until fully vested on 8/01/17.

11. Does not include 143 shares underlying the option that were previously exercised and sold.

12. 1/12th of the 322 shares subject to the option granted on 10/24/14 vested or shall vest and became or shall become exercisable each quarter commencing on 1/24/15 until fully vested on 10/24/17.

13. Does not include 53 shares underlying the option that were previously exercised and sold.

14. 1/12th of the 322 shares subject to the option granted on 1/30/15 vested or shall vest and became or shall become exercisable each quarter commencing on 4/30/15 until fully vested on 1/30/18.

15. Does not include 26 shares underlying the option that were previously exercised and sold.

16. 1/12th of the 322 shares subject to the option granted on 4/24/15 vested or shall vest and became or shall become exercisable each quarter commencing on 7/24/15 until fully vested on 4/24/18.

17. 1/12th of the 322 shares subject to the option granted on 7/31/15 vested or shall vest and became or shall become exercisable each quarter commencing on 10/31/15 until fully vested on 7/31/18.

18. 1/12th of the 704 shares subject to the option granted on 10/23/15 vested or shall vest and became or shall become exercisable each quarter commencing on 1/23/16 until fully vested on 10/23/18.

19. 1/12th of the 705 shares subject to the option granted on 1/29/16 vested or shall vest and became or shall become exercisable each quarter commencing on 4/29/16 until fully vested on 1/29/19.

20. 1/12th of the 705 shares subject to the option granted on 4/29/16 vested or shall vest and became or shall become exercisable each quarter commencing on 7/29/16 until fully vested on 4/29/19.

21. 1/12th of the 705 shares subject to the option granted on 7/29/16 vested or shall vest and became or shall become exercisable each quarter commencing on 10/29/16 until fully vested on 7/29/19.

Remarks:

The reporting person is the Vice President and General Manager of the PC division. Exhibit List Exhibit 24 - Limited Power of Attorney

	Kermit Nolan, as Attorney-in-Fact	08/02/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.